AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

DUKEMOUNT CAPITAL PLC

Regulatory Filings Mar 26, 2020

4974_bfr_2020-03-26_46e4aca6-3227-488c-b786-75cd2061a58b.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6079H

Dukemount Capital PLC

26 March 2020

Dukemount Capital PLC

26 March 2020  

26 March 2020

Dukemount Capital Plc

("Dukemount" or "the Company")

Update on Wavertree Project

The board would like to direct shareholders to the project section of the website where we have today uploaded some recent photos of the Wavertree project. http://dukemountcapitalplc.com/development-projects.php

Despite an unprecedented six months involving Brexit, a General Election and now the Coronavirus pandemic, the 16 apartments and offices in the Wavertree project in North West England are in final fit out. We remain in close contact with the architects and contractors with regards to the Coronavirus situation and will update as soon as we are informed of any potential change to Government advice with regards to construction sites.

For further information, please visit www.dukemountcapitalplc.com or contact:

Dukemount Capital Plc Via St Swithins PR
Geoffrey Dart
St Swithins PR (Media and Investor Enquiries) Tel: +44 (0) 1732 521132
Gary Middleton [email protected]
Peterhouse Capital  Limited Tel: +44 (0) 207 469 0930
Lucy Williams/Duncan Vasey

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

UPDUVSVRRVUOUAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.